UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice.
about
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
UniPR1331, a small molecule ta ...... ntiangiogenic therapy in mice.
@en
UniPR1331, a small molecule ta ...... ntiangiogenic therapy in mice.
@nl
type
label
UniPR1331, a small molecule ta ...... ntiangiogenic therapy in mice.
@en
UniPR1331, a small molecule ta ...... ntiangiogenic therapy in mice.
@nl
prefLabel
UniPR1331, a small molecule ta ...... ntiangiogenic therapy in mice.
@en
UniPR1331, a small molecule ta ...... ntiangiogenic therapy in mice.
@nl
P2093
P2860
P356
P1433
P1476
UniPR1331, a small molecule ta ...... ntiangiogenic therapy in mice.
@en
P2093
Alessandro Colapietro
Alessio Lodola
Andrea Mancini
Annamaria Cantoni
Carmine Giorgio
Claudio Festuccia
Cristina Pellegrini
Federica Vacondio
Giovanni Luca Gravina
Marco Rusnati
P2860
P304
24347-24363
P356
10.18632/ONCOTARGET.25272
P407
P577
2018-05-11T00:00:00Z